Eleusis Benefit
-
2013
Company Description
Eleusis Benefit Corporation seeks to develop and repurpose restricted small molecule drugs to safely address critical unmet needs.
Eleusis Benefit is a UK-based life science company that explores the therapeutic potential of serotonin receptor 2A agonists. Eleusis Benefit Corporation seeks to develop and repurpose restricted small molecule drugs to safely address critical unmet needs.
-
Manufacturer:
Science and Engineering -
Formed:
2013 -
Founders:
Shlomi Raz -
Company Website:
-
Company E-mail:
-
Company Address:
11 East 44th Street, Suite 704New York, NYUnited States -
CEO:
- Shlomi Raz
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits